Sage Therapeutics
SAGE
$11.90
Share price
-3.57%
Change (1 day)
-77.37%
Change (1 year)
Categories
Sage Therapeutics (SAGE) - Total debt
Total debt on the balance sheet as of March 2024 : $3.3 M
According to Sage Therapeutics 's latest financial reports the company's total debt is $3.3 M. A company’s total debt is the sum of all current and non-current debts.
Sage Therapeutics - Total debt on balance sheet (from 2018 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $5.16 M | -57.43% |
| 2022-12-31 | $12.13 M | -34.17% |
| 2021-12-31 | $18.43 M | -34.41% |
| 2020-12-31 | $28.1 M | -24.24% |
| 2019-12-31 | $37.09 M | |
| 2018-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Regulus Therapeutics RGLS | $2.38 M | -27.74% | 🇺🇸 USA |
 Intercept Pharmaceuticals
ICPT | $0.22 B | 6,671.20% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $2.55 B | 77,258.14% | 🇮🇪 Ireland |
 Eagle Pharmaceuticals
EGRX | $71.61 M | 2,066.21% | 🇺🇸 USA |